research High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
In this study, the researchers observed that the severity of capecitabine-induced hand-foot syndrome in advanced gastric cancer patients was not linked to the IVS14+1G→A mutation in the DPYD gene.


